FI921595L - Rapamycinkarbamater - Google Patents

Rapamycinkarbamater Download PDF

Info

Publication number
FI921595L
FI921595L FI921595A FI921595A FI921595L FI 921595 L FI921595 L FI 921595L FI 921595 A FI921595 A FI 921595A FI 921595 A FI921595 A FI 921595A FI 921595 L FI921595 L FI 921595L
Authority
FI
Finland
Prior art keywords
carbamater
rapamycin
rapamycin carbamater
Prior art date
Application number
FI921595A
Other languages
English (en)
Finnish (fi)
Other versions
FI921595A7 (fi
FI921595A0 (fi
Inventor
Wenling Kao
Robert Lewis Vogel
John Henry Musser
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/686,728 external-priority patent/US5118678A/en
Priority claimed from US07/837,048 external-priority patent/US5194447A/en
Application filed by American Home Prod filed Critical American Home Prod
Publication of FI921595A0 publication Critical patent/FI921595A0/fi
Publication of FI921595A7 publication Critical patent/FI921595A7/fi
Publication of FI921595L publication Critical patent/FI921595L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI921595A 1991-04-17 1992-04-10 Rapamycinkarbamater FI921595L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/686,728 US5118678A (en) 1991-04-17 1991-04-17 Carbamates of rapamycin
US07/837,048 US5194447A (en) 1992-02-18 1992-02-18 Sulfonylcarbamates of rapamycin

Publications (3)

Publication Number Publication Date
FI921595A0 FI921595A0 (fi) 1992-04-10
FI921595A7 FI921595A7 (fi) 1992-10-18
FI921595L true FI921595L (fi) 1992-10-18

Family

ID=27103855

Family Applications (1)

Application Number Title Priority Date Filing Date
FI921595A FI921595L (fi) 1991-04-17 1992-04-10 Rapamycinkarbamater

Country Status (12)

Country Link
EP (1) EP0509795A2 (enExample)
JP (1) JPH05112573A (enExample)
KR (1) KR920019798A (enExample)
AU (1) AU642592B2 (enExample)
CZ (1) CZ117392A3 (enExample)
FI (1) FI921595L (enExample)
HU (1) HU9201254D0 (enExample)
IE (1) IE921249A1 (enExample)
MX (1) MX9201710A (enExample)
NO (1) NO921449L (enExample)
NZ (1) NZ242367A (enExample)
SK (1) SK117392A3 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776943A (en) * 1991-05-14 1998-07-07 American Home Products Corporation Rapamycin metabolites
US5118677A (en) * 1991-05-20 1992-06-02 American Home Products Corporation Amide esters of rapamycin
WO1993018043A1 (en) * 1992-03-05 1993-09-16 American Home Products Corporation Novel rapamycin 42-sulfonates and 42-(n-carboalkoxy)sulfamates useful as immunosuppressive agents
GB9307491D0 (en) * 1993-04-08 1993-06-02 Sandoz Ltd Organic compounds
CH686761A5 (de) 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
JP4105761B2 (ja) * 1993-11-19 2008-06-25 アボット・ラボラトリーズ ラパミシン(マクロライド)の半合成類似体免疫調節剤
US5527907A (en) * 1993-11-19 1996-06-18 Abbott Laboratories Macrolide immunomodulators
US5362718A (en) 1994-04-18 1994-11-08 American Home Products Corporation Rapamycin hydroxyesters
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
ATE538794T1 (de) 1999-01-13 2012-01-15 Bayer Healthcare Llc Gamma carboxyarylsubstituierte diphenylharnstoffverbindungen als p38 kinasehemmer
PT1210350E (pt) * 1999-08-18 2004-10-29 Wyeth Corp Esteres de sdz-rad soluveis em agua
MXPA04007832A (es) 2002-02-11 2005-09-08 Bayer Pharmaceuticals Corp Aril-ureas con actividad inhibitoria de angiogenesis.
UY28213A1 (es) 2003-02-28 2004-09-30 Bayer Pharmaceuticals Corp Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos.
EP1636585B2 (en) 2003-05-20 2012-06-13 Bayer HealthCare LLC Diaryl ureas with kinase inhibiting activity
HRP20060073B1 (hr) 2003-07-23 2014-03-14 Bayer Healthcare Llc Fluoro supstituirana omega-karboksiaril difenil urea za lijeäśenje i prevenciju bolesti i stanja
WO2005042567A1 (en) * 2003-11-03 2005-05-12 Altachem Pharma Ltd. Rapamycin peptides conjugates: synthesis and uses thereof
US8021849B2 (en) 2004-11-05 2011-09-20 Siemens Healthcare Diagnostics Inc. Methods and kits for the determination of sirolimus in a sample
EP1856131A1 (en) 2005-03-07 2007-11-21 Wyeth Oxepane isomer of 42-o-(2-hydroxy)ethyl-rapamycin
US7189582B2 (en) 2005-04-27 2007-03-13 Dade Behring Inc. Compositions and methods for detection of sirolimus
JP2022518526A (ja) * 2019-01-25 2022-03-15 ノッドセラ リミテッド カルバメート誘導体およびその使用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4885171A (en) * 1978-11-03 1989-12-05 American Home Products Corporation Use of rapamycin in treatment of certain tumors
US4316885A (en) * 1980-08-25 1982-02-23 Ayerst, Mckenna And Harrison, Inc. Acyl derivatives of rapamycin
US4650803A (en) * 1985-12-06 1987-03-17 University Of Kansas Prodrugs of rapamycin
AU6286690A (en) * 1989-08-18 1991-04-03 Fisons Plc Macrocyclic compounds
PT98990A (pt) * 1990-09-19 1992-08-31 American Home Prod Processo para a preparacao de esteres de acidos carboxilicos de rapamicina
US5118677A (en) * 1991-05-20 1992-06-02 American Home Products Corporation Amide esters of rapamycin

Also Published As

Publication number Publication date
MX9201710A (es) 1993-01-01
FI921595A7 (fi) 1992-10-18
NO921449D0 (no) 1992-04-10
EP0509795A3 (enExample) 1994-03-23
SK117392A3 (en) 1995-04-12
AU1488092A (en) 1992-10-22
HU9201254D0 (en) 1992-07-28
EP0509795A2 (en) 1992-10-21
FI921595A0 (fi) 1992-04-10
NZ242367A (en) 1994-07-26
IE921249A1 (en) 1992-10-21
JPH05112573A (ja) 1993-05-07
NO921449L (no) 1992-10-19
CZ117392A3 (en) 1993-09-15
KR920019798A (ko) 1992-11-20
AU642592B2 (en) 1993-10-21

Similar Documents

Publication Publication Date Title
FI931203A0 (fi) Karboxylsyraestrar av rapamycin
DE69332540D1 (de) Rapamycinderivate
DE69332484D1 (de) Rapamycinderivate
FI922431L (fi) Bicykliska rapamyciner
FI922432A7 (fi) Rapamysiinidimeerejä
ATE137279T1 (de) Stoffauflauf
FI921595L (fi) Rapamycinkarbamater
DE69332582D1 (de) Rapamycinderivate
ATA131391A (de) Reibring
FI910116L (fi) sigma-delta-modulator foer d/a-omvandlare
FI930118L (fi) Kylande anordning
ATA39792A (de) Maehwerk
ATA170491A (de) Mauerstein
FI925317A0 (fi) Makrocykliska laktamderivat
ATE163916T1 (de) Ethyl-6-formyloxy-4-hexenoat
ATA67791A (de) Rollski
ATA9892A (de) Formstein
BR9100097A (pt) Controlador de rondas-cr55-10
BR9100879A (pt) Pre-fluidificador de gasoleo
FI924271L (fi) Saoningsanordning
BR7101883U (pt) Boomerangue
BR7102405U (pt) Chutegol
ATA188391A (de) Alpinski
ATA235591A (de) Eluiergeraet
BR7100443U (pt) Vigier